Vesugen

Vesugen is a synthetic peptide, identified by the amino acid sequence lysine-glutamic acid-aspartic acid (Lys-Glu-Asp). It belongs to a class of synthetic peptides designed to mimic the actions of naturally occurring bioregulators. Research into Vesugen primarily focuses on its potential role in regulating elements of the vascular system. This peptide is not a vitamin, mineral, or conventional drug, but rather a compound under scientific investigation for its potential biological activities, particularly concerning circulatory health. Its development stems from a line of research exploring short peptides as potential therapeutic or prophylactic agents. Vesugen is typically administered via injection in research settings, with a relatively short half-life of approximately one hour, meaning it is quickly processed by the body. As an investigational compound, its precise mechanisms and effects are still being elucidated, and it is not approved for medical use outside of research contexts. (PubChem, DrugBank)